These surgeries involve no bone cuts, minimal surgical trauma, smaller incisions and significantly reduced blood loss
The patent protects antiviral compounds developed by the company that inhibit Vacuolar ATPase (V-ATPase) activity in cells, a mechanism involved in viral infection pathways
KeyCi’s dermatologically tested lineup emphasizes clean formulations—vegan, cruelty-free, alcohol-free, and paraben-free—while being backed by pharmaceutical-grade research and FDA approval
Venglustat, a glucosylceramide synthase inhibitor (GCSi), works by reducing the abnormal buildup of sugar-and-fat molecules in cells and organs
The integration unifies brand and field strategy, drives executional alignment, and delivers immediate impact measurement
The move strengthens GBL’s clinical-stage presence in the United States
Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
